Quick Answer
AURORA CANNABIS INC reported r&d expense of C$3.68 million for fiscal year 2025 (IFRS, Form 20-F).
Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.
AURORA CANNABIS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | C$3.68M | +2.9% |
| 2024 | C$3.57M | -65.6% |
| 2022 | C$10.39M | -9.2% |
| 2021 | C$11.45M | -56.0% |
| 2020 | C$26.03M | +76.1% |
| 2019 | C$14.78M | +780.2% |
| 2018 | C$1.68M | — |
- AURORA CANNABIS INC’s r&d expense rose 2.9% year over year.
- The most recent figure is from AURORA CANNABIS INC’s fiscal year 2025 annual report (Form 20-F), filed June 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.
Last verified: